Skip to main content
Clinical Trials/NCT06609317
NCT06609317
Recruiting
N/A

Feasibility of Pelvic Floor Muscle Training With a Digital Therapeutic Motion-based Device (Leva Device) in a Postpartum Population

University of South Florida2 sites in 1 country25 target enrollmentApril 4, 2025

Overview

Phase
N/A
Intervention
Not specified
Conditions
Postpartum Pelvic Floor Function and Symptoms
Sponsor
University of South Florida
Enrollment
25
Locations
2
Primary Endpoint
Feasibility
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device.

In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum.

Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.

Registry
clinicaltrials.gov
Start Date
April 4, 2025
End Date
February 1, 2026
Last Updated
9 months ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Spontaneous vaginal delivery within the last 4-8 weeks
  • Age ≥ 18 years
  • Ambulatory
  • Willing and able to consent to participate.
  • English speaking
  • Owns a smartphone

Exclusion Criteria

  • Operative or cesarean delivery
  • Obstetric delivery at less than 20 weeks gestation
  • Third- or fourth-degree perineal laceration
  • Episiotomy
  • Multiples

Outcomes

Primary Outcomes

Feasibility

Time Frame: From enrollment to 6 months postpartum

Feasibility will be assessed using participant reported discomfort with device use, ease of device use, net promotor score, patient satisfaction, and free text feedback on the device.

Perineal Pain

Time Frame: From enrollment to 6 months postpartum

Participants will complete validated surveys assessing perineal pain at baseline, 3 months postpartum, and 6 months postpartum.

Secondary Outcomes

  • Bladder function(From enrollment to 6 months postpartum)
  • Bowel Function(From enrollment to 6 months postpartum)
  • Pelvic Organ Prolapse(From enrollment to 6 months postpartum)
  • Vaginal pain(From enrollment to 6 months postpartum)
  • Sexual function(From enrollment to 6 months postpartum)

Study Sites (2)

Loading locations...

Similar Trials